Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort

Bálint Anita, Rutka Mariann, Végh Zsuzsanna, Kürti Zsuzsanna, Gecse Krisztina B., Lakatos László, Szepes Zoltán, Vincze Áron, Bor Renáta, Milassin Ágnes, Fábián Anna, Nagy Ferenc, Lakatos Péter László, Molnár Tamás, Farkas Klaudia: Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort.
EXPERT OPINION ON DRUG SAFETY, (16) 8. pp. 885-890. ISSN 1474-0338 (2017)

[img]
Preview
Text
3225452_Balint_EODS_2017l_u.pdf - Published Version

Download (1MB) | Preview
Item Type: Article
Journal or Publication Title: EXPERT OPINION ON DRUG SAFETY
Date: 2017
Volume: 16
Number: 8
Page Range: pp. 885-890
ISSN: 1474-0338
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
SWORD language: Angol
Identification Number: 3225452
DOI id: https://doi.org/10.1080/14740338.2017.1323330
Date Deposited: 2017. Sep. 29. 12:10
Last Modified: 2017. Sep. 29. 12:10
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12010

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year